MedTrace Logo

The OPBC-07/microNAC Study

NCT06529302 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2025-01-24

No results posted yet for this study

Summary

The aim of this multicenter retrospective cohort study is to determine the safety of omission of axillary lymph node dissection in patients with residual micrometastases after neoadjuvant chemotherapy.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Walter Paul Weber, Prof. Dr. · University Hospital, Basel, Switzerland

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-15
Primary Completion
2025-06-30
Completion
2025-06-30

Countries

  • United States
  • Argentina
  • Australia
  • Austria
  • Brazil
  • Canada
  • Chile
  • Croatia
  • Egypt
  • Germany
  • Greece
  • Israel
  • Italy
  • Latvia
  • Lithuania
  • Netherlands
  • Norway
  • Pakistan
  • Peru
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Slovenia
  • South Korea
  • Spain
  • Sweden
  • Switzerland
  • Turkey (Türkiye)
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06529302 on ClinicalTrials.gov